Wegovy, Ozempic not linked to increase in suicidal thoughts, US study finds

A large U.S. study found no evidence that taking Novo Nordisk's Ozempic or Wegovy is tied to an increase in suicidal thoughts, researchers reported on Friday. Both Ozempic for type 2 diabetes and the obesity treatment Wegovy have the same active ingredient, semaglutide. Instead, the analysis of electronic medical record data from more than 1.8 million patients found a lower risk of new and recurrent suicidal thoughts in those taking semaglutide compared to those using other medications for weight loss or diabetes.